Prescription Drug Sunitinib Malate Subject to Label Mix-Up Recall
AvKARE is recalling 40 bottles of Sunitinib Malate Capsules due to a label mix-up. The affected lot was distributed nationwide in the United States.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall meets the rubric criterion for 'risk-of-harm products where injury has not yet been reported'—a prescription drug with a labeling mix-up presents potential for patient harm, though no illnesses or injuries are explicitly reported in the source.
Plain-English summary
AvKARE is recalling 40 bottles of Sunitinib Malate Capsules, 12.5 mg, due to a labeling mix-up. The recall affects Lot #100049371 with an expiration date of July 31, 2026, identified by NDC 42291-901-28.
The affected bottles were distributed nationwide within the United States.
Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance. Healthcare providers and pharmacists should identify and quarantine affected stock from Lot #100049371 and verify that patients have received correct medication.
The recalled product
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100049371
- Exp. Date 07/31/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by AvKARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · SUNITINIB MALATE
- HighSunitinib Malate Capsules Recalled Due to Label Mix-Up
FDA (Drugs) · 2024-12-11
- HighSunitinib Malate Capsules Recalled Due to Excess Moisture Content
FDA (Drugs) · 2023-07-19
Same manufacturer · AvKARE
See all →- HighAmantadine hydrochloride capsules recalled after failing dissolution specifications
FDA (Drugs) · 2026-03-04
- ModerateRosuvastatin tablets recalled after failing a dissolution specification
FDA (Drugs) · 2026-01-14
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighAvKare chlorpromazine 100 mg cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
- HighAvKare chlorpromazine unit dose cartons recalled over presence of foreign substance
FDA (Drugs) · 2025-09-17
Same hazard · label mix up
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- SevereBuffered penicillin G potassium vials may actually contain cefazolin for injection
FDA (Drugs) · 2025-07-09
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- ModerateEye drops recalled nationwide due to labeling mix-up
FDA (Drugs) · 2025-01-08
- ModerateWindsor Black Peppercorns Mislabeled; Contains Pink Himalayan Salt Instead
FDA (Food) · 2024-04-24